VRTX
VERTEX PHARMACEUTICALS INC / MA
VERTEX PHARMACEUTICALS INC / MA (VRTX) Financials
Annual revenue, profit, EPS and free cash flow for VRTX, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $12.0B | — | $4.2B | $4.0B | $15.32 | $3.2B |
| FY2024 | $11.0B | — | $-232.9M | $-535.6M | -$2.08 | $-790.3M |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.